TET 830 modified/T – helper epitope from tetanus toxoid

Product Name
TET 830 modified/T – helper epitope from tetanus toxoid
A Phase I trial was carried out to assess both the safety and the immunological response of a melanoma vaccine. This vaccine incorporates the HLA-A2-restricted peptide YLEPGPVTA (gp100(280)), with the option of including a modified T-helper epitope sourced from tetanus toxoid, known as AQYIKANSKFIGITEL. AQYIKANSKFIGITEL, also referred to as TET 830 modified T-helper epitope from tetanus toxoid, serves as a universal human tetanus toxin T cell epitope. Its primary function is to induce T-cell activation, making it a valuable helper peptide in various vaccination strategies.
Product Quantity
Catalog Number
Molecular Weight
Ala-Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu, AQYIKANSKFIGITEL
  • 5 Units in Stock

Ask a Question


Add to Cart:
LifeTein LifeTein provides custom peptide synthesis service, recombinant proteins, peptides, cytokines, custom antibody service and custom protein service. LifeTein is the world leader in fast peptide synthesis service with lab facility located in New Jersey USA. LifeTein Peptide 100 Randolph Road, Suite 2D, Somerset USA New Jersey 08873
Copyright © 2024 LifeTein.com. Powered by LifeTein